CARY, N.C., June 22, 2020—Biologics by McKesson, an independent specialty pharmacy and patient services company specializing in oncology, rare diseases and other complex therapeutic areas, is pleased to announce that Brandon Tom, PharmD, was named its new general manager. Tom’s appointment will play a critical role in supporting Biologic’s continual growth strategy, ongoing focus on patients, increased access to therapies and drive to lead the rare, complex and oncology specialty pharmacy space.
As general manager, Tom will continue to be based in Cary, North Carolina, and will oversee all aspects of the Biologics business including operations, quality, payer relations, sales and marketing, account management, IT and, most importantly, culture.
“Biologics is a stellar organization with passionate people who keep the patient at the heart of everything they do,” Tom said. “Since joining Biologics more than three years ago, I have had the opportunity to see the amazing support we offer patients as well as work with passionate provider and biopharma customers, and I look forward to continuing to enhance our services for those stakeholders. We are well positioned in the market to significantly grow this business, and I’m humbled to lead this team into the future with the mission of supporting patients with their holistic medication needs.”
Tom came to McKesson in 2008. He advanced quickly through various leadership positions within our specialty businesses including the Onmark Group Purchasing Organization (GPO), The US Oncology Network, Specialty Distribution and Trade, and Corporate Strategy. He also played an integral role in both the acquisition and integration process of Biologics into the McKesson enterprise in 2016. Tom was later promoted to vice president of Commercial Services where his role expanded to lead all the growth functions within the business, including provider sales, sales support, clinical innovation and strategy.
“Brandon’s energy, enthusiasm and influential leadership combined with his deep understanding of specialty pharmacy, oncology and distribution services, make him the ideal candidate to lead Biologics,” said Pete Perron, president of Provider Solutions for McKesson. “I look forward to him and his team growing the business so we can provide even more patients with the life-changing therapies they need and deserve.”
About Biologics by McKesson
Biologics by McKesson is an independent specialty pharmacy with more than 25 years of experience connecting patients to life-changing medications in oncology and other rare and complex therapeutic areas. Built on the foundation of deep clinical expertise and a high-touch approach to patient care, Biologics delivers seamless access and personalized engagement, so patients get the most out of the care they receive. As part of McKesson Life Sciences, a business within McKesson Corporation, Biologics harnesses unparalleled reach and connectivity across the healthcare system to connect the dots between payers, providers and biopharma, so together, they can deliver better care and outcomes for every patient.
Claire Crye, Public Relations